IL79699A - Antiviral compositions containing 2',3'-dideoxycytidine or its mono-or triphosphate - Google Patents

Antiviral compositions containing 2',3'-dideoxycytidine or its mono-or triphosphate

Info

Publication number
IL79699A
IL79699A IL79699A IL7969986A IL79699A IL 79699 A IL79699 A IL 79699A IL 79699 A IL79699 A IL 79699A IL 7969986 A IL7969986 A IL 7969986A IL 79699 A IL79699 A IL 79699A
Authority
IL
Israel
Prior art keywords
dideoxycytidine
mono
triphosphate
compositions containing
antiviral compositions
Prior art date
Application number
IL79699A
Other languages
English (en)
Other versions
IL79699A0 (en
Original Assignee
Us Commerce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Us Commerce filed Critical Us Commerce
Publication of IL79699A0 publication Critical patent/IL79699A0/xx
Publication of IL79699A publication Critical patent/IL79699A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL79699A 1985-08-26 1986-08-12 Antiviral compositions containing 2',3'-dideoxycytidine or its mono-or triphosphate IL79699A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76901785A 1985-08-26 1985-08-26

Publications (2)

Publication Number Publication Date
IL79699A0 IL79699A0 (en) 1986-11-30
IL79699A true IL79699A (en) 1992-07-15

Family

ID=25084170

Family Applications (1)

Application Number Title Priority Date Filing Date
IL79699A IL79699A (en) 1985-08-26 1986-08-12 Antiviral compositions containing 2',3'-dideoxycytidine or its mono-or triphosphate

Country Status (12)

Country Link
EP (1) EP0216511B1 (de)
JP (1) JPS62501777A (de)
AT (1) ATE96326T1 (de)
AU (1) AU570855B2 (de)
CA (1) CA1277915C (de)
DE (1) DE3689221T2 (de)
HK (1) HK67995A (de)
IE (1) IE63001B1 (de)
IL (1) IL79699A (de)
NL (1) NL940019I2 (de)
NZ (1) NZ217184A (de)
WO (1) WO1987001283A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960001372B1 (ko) * 1986-09-24 1996-01-26 예일 유니버시티 레트로비루스로 감염된 환자의 치료에 사용되는 2',3'-디디옥시사이티딘-2'-엔(2',3'-디디옥시-2',3'-디디하이드로사이티딘)의 항생물질
GB8712691D0 (en) * 1987-05-29 1987-07-01 Wellcome Found Therapeutic nucleosides
IL86007A0 (en) * 1987-04-09 1988-09-30 Wellcome Found 6-substituted purine nucleosides,their preparation and pharmaceutical compositions containing them
IL86009A (en) * 1987-04-10 1991-09-16 Us Health Liposome-encapsulated phosphorylated nucleosides for treatment of retroviral diseases
EP0294113A1 (de) * 1987-05-29 1988-12-07 The Wellcome Foundation Limited Therapeutische Nucleoside
US5028595A (en) * 1987-09-18 1991-07-02 Hoffmann-La Roche Inc. Method for preventing AIDS in a subject or treating a subject infected with the AIDS virus
JP2648329B2 (ja) * 1987-09-18 1997-08-27 エフ・ホフマン−ラ ロシュ アーゲー エイズの予防または治療用医薬組成物
WO1989002733A1 (en) * 1987-09-22 1989-04-06 The Regents Of The University Of California Liposomal nucleoside analogues for treating aids
WO1990014079A1 (en) * 1989-05-15 1990-11-29 The United States Of America, Represented By The Secretary, United States Department Of Commerce Method of treatment of hepatitis
US5071983A (en) * 1989-10-06 1991-12-10 Burroughs Wellcome Co. Therapeutic nucleosides
US5192749A (en) * 1990-05-21 1993-03-09 Syntex (U.S.A.) Inc. 4'-substituted nucleosides
CA2270600A1 (en) 1999-05-03 2000-11-03 Infectio Recherche Inc. Method and formulations for the treatment of diseases, particularly those caused by human immunodeficiency virus and leishmania

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ216172A (en) * 1985-05-15 1989-08-29 Wellcome Found Nucleosides and pharmaceutical compositions

Also Published As

Publication number Publication date
IE862264L (en) 1987-02-26
AU6284386A (en) 1987-03-24
NL940019I1 (nl) 1994-12-01
WO1987001283A1 (en) 1987-03-12
AU570855B2 (en) 1988-03-24
IE63001B1 (en) 1995-03-08
EP0216511A2 (de) 1987-04-01
HK67995A (en) 1995-05-12
JPH0215524B2 (de) 1990-04-12
ATE96326T1 (de) 1993-11-15
NL940019I2 (nl) 1997-07-01
EP0216511B1 (de) 1993-10-27
DE3689221T2 (de) 1994-02-24
NZ217184A (en) 1990-03-27
EP0216511A3 (en) 1989-08-02
JPS62501777A (ja) 1987-07-16
IL79699A0 (en) 1986-11-30
CA1277915C (en) 1990-12-18
DE3689221D1 (de) 1993-12-02

Similar Documents

Publication Publication Date Title
NZ217185A (en) Alleviating cytopathic effects of htlv-iii virus on cells; pharmaceutical composition
PH21250A (en) Sucralfate supsension
MY102025A (en) Improvements in or relating to novel difluoro antiviral agents
DK164870C (da) Fremgangsmaade til fremstilling af acarbose med et acarbose-indhold paa mindst 90 vaegtprocent paa toerstofbasis, eller en vandig oploesning deraf
IL89921A0 (en) 1,3-dioxolane derivatives and pharmaceutical compositions containing the same
AU1261488A (en) Substituted 9-(1 or 3-monoacyloxy or 1,3-diacyloxy-2-propoxymethyl) purines as antiviral agent
IL79699A0 (en) Antiviral compositions containing 2',3'-dideoxycytidine or its mono-or triphosphate
DK631688A (da) 2',3'-dideoxy-2'-fluornucleosider, fremstillingen deraf samt praeparater indeholdende samme
NZ222935A (en) Antiviral composition containing 3'deoxythymidin-2-ene
EP0207158A4 (de) Antiasthma-zubereitung enthaltend 8,11,14,17-eikosatetraenoesäure.
AU5864980A (en) Urea stabilized by dicyandiamide
ZA822854B (en) 4'-halo-substituted sucrose derivatives
HUT44011A (en) Herbicide compositions containing n-substituted-3,4,5,6-tetrahydro-phtalimide derivatives as active components and process for producing the active components
PT82074A (en) An arrangement for the assembly of frontal handrails to children's pushchaiers or sirollers
AU591525B2 (en) Stabilization of interferons
ZA804036B (en) Sulfonamide compositions
AU551407B2 (en) Crystalline human leukocyte interferon
DK163926C (da) 6-halogen- eller 6,6-dihalogen-1,1-dioxopenicillanoyloxy-methyl-6-oed-2-(2-alkoxycarbonyl-1-methylvinylamino- eller 1-methyl-3-oxo-1-butenylamino)-2-phenylacetamidoaapenicillanater
Bain Effects of weld undercutting on the fatique life of plate" T"-welded specimens.
Moore A comparison of the calculation schemes for computing weld cooling.
Harford Comparative study of two inference control techniques
Asadov Phase diagram of the Hg-Tl-S system.
ES8701506A1 (es) Una membrana semipermeable
ES267942Y (es) "un aparato concentrador de oxigeno".
IT8025582A0 (it) Circuito per l'eliminazione dei disturbi.

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
EXP Patent expired